公司概覽
業務類別 Diagnostics & Research
業務概覽 Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest countryconcentrations.
公司地址 5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
電話號碼 +1 800 227-9770
傳真號碼 --
公司網頁 https://www.agilent.com
員工數量 18100
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jonah Prevost Kirkwood Senior Vice President, Agilent and Chief Commercial Officer, Commercial Organization -- 22/12/2025
Ms. Angelica A. Reimann Senior Vice President, Agilent and President, Agilent CrossLab Group 美元 591.35K 22/12/2025
Mr. Bret M. DiMarco Senior Vice President, Agilent and Chief Legal Officer and Secretary 美元 679.81K 22/12/2025
Mr. Rodney Gonsalves Vice President, Corporate Controller and Principal Accounting Officer 美元 513.56K 06/03/2026
Ms. Meghan Henson Senior Vice President, Agilent and Chief Human Resources Officer -- 22/12/2025
Mr. Adam S. Elinoff Senior Vice President and Chief Financial Officer -- 22/12/2025
Mr. Padraig McDonnell President, Director and Chief Executive Officer 美元 1.14M 06/02/2026
Mr. Simon May Senior Vice President, Agilent and President, Life Sciences and Diagnostics Markets Group 美元 635.39K 22/12/2025
Mr. Mike Zhang Senior Vice President, Agilent and President, Applied Markets Group -- 22/12/2025
 
董事會成員
董事會 職務 更新日期
Mr. Dow R. Wilson Independent Director 06/02/2026
Dr. George A. Scangos,PhD Independent Director 06/02/2026
Dr. Otis W. Brawley,M.D. Independent Director 06/02/2026
Dr. Daniel K. Podolsky, M.D. Independent Director 06/02/2026
Mr. Boon Hwee Koh Chairman of the Board 06/02/2026
Mr. Pascal Soriot Independent Director 06/02/2026
Dr. G. Mikael Dolsten, M.D.,PhD Independent Director 06/02/2026
Ms. Susan H. Rataj Independent Director 06/02/2026
Ms. Mala Anand Independent Director 06/02/2026
Ms. Judy Gawlik Brown Independent Director 06/02/2026
Mr. Padraig McDonnell President, Director and Chief Executive Officer 06/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:00)
代號 名稱 佔比% 持有日期
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%27/02/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.0001%27/02/2026
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%27/02/2026
XVOLAcruence Active Hedge US Equity ETF0.0001%27/02/2026
QARPXtrackers Russell 1000 US QARP ETF0.0001%26/02/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0001%27/02/2026
PQUSPictet AI Enhanced US Equity ETF0.0001%27/02/2026
GOFGuggenheim Strategic Opp Fund0.00005%30/11/2025
QRFTQRAFT AI-Enhanced US Large Cap ETF0.00004%27/02/2026
MPLYMonopoly ETF0.00003%27/02/2026
INROiShares U.S. Industry Rotation Act ETF0.00002%28/02/2026
CHRIGlobal X S&P 500 Christian Values ETF0.00001%27/02/2026
SPUTInnovator Eq Prm Inc -Daily PutWrite ETF0.00001%23/02/2026
RVRBReverb ETF0.00001%27/02/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.00001%26/02/2026
GXLCGlobal X U.S. 500 ETF0.00001%27/02/2026
XCLRGlobal X S&P 500® Collar 95-110 ETF0.00001%27/02/2026
XTRGlobal X S&P 500® Tail Risk ETF0.000004%27/02/2026
FBProshares S&P 500 Dynamic Buffer ETF0.000003%30/11/2025
AAAAAmplius Aggressive Asset Allocation ETF<0.000001%24/07/2025
  1    2    3    4    5    6    7    8    9    10   11    12    13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.